Sterol 27-hydroxylase- and apoAI/phospholipid-mediated efflux of cholesterol from cholesterol-laden macrophages: Evidence for an inverse relation between the two mechanisms

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 4, 1998, Pages 554-561

  Westman, Jan ^a   Kallin, Bengt ^a   Björkhem, Ingemar ^b   Nilsson, Jan ^a   Diczfalusy, Ulf ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

27 hydroxylase; 27 oxygenated sterols; Cholesterol acceptor; Foam cell macrophages; HDL

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OXYGENASE;

ARTICLE; ATHEROSCLEROSIS; CELL LEVEL; CELL METABOLISM; CHOLESTEROL METABOLISM; ENZYME ACTIVITY; FOAM CELL; HUMAN; HUMAN CELL; MACROPHAGE; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0031955904     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.4.554     Document Type: Article

References (15)

1. Björkhem I, Andersson O, Diczfalusy U, Sevastik B, Xiu R-J, Duan C, Lund E. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci USA. 1994;91:8592-8596.
2. Holmberg-Betsholtz I, Lund E, Björkhem I, Wikvall K. Sterol 27-hydroxylase in bile acid biosynthesis. J Biol Chem. 1993;268:11079-11085.
3. Lund E, Andersson O, Zhang J, Babiker A, Ahlborg G, Diczfalusy U, Einarsson K, Sjövall J, Björkhem I. Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arterioscler Thromb Vasc Biol. 1996;16:208-212.
4. Björkhem I. Mechanism of degradation of the steroid side chain in the formation of bile acids. J Lipid Res. 1992;33:455-471.
5. Andersson S, Davies DL, Dahlbäck H, Jörnvall H, Russel DW. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem. 1989;264:8222-8229.
6. 27-steroid 26-hydroxylase activity from bovine brain mitochondria. Biochem Int. 1989:18:615-622.
7. 27-steroids in human skin fibroblasts, and a deficiency of this activity in cerebrotendinous xanthomatosis. J Clin Invest. 1986;78:729-735.
8. Kuriyama M, Fujiyama J, Yoshidome H, Takenaga S, Matsumuro K, Kasama T, Fukuda K, Kuramoto T, Hoshita T, Seyama Y, Okatu Y, Osame M. Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature. J Neurol Sci. 1991;102:225-232.
9. Milano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission. Am J Hum Genet. 1985:37:1083-1097.
10. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol. 1976;5(suppl. 5):9-15.
11. Basu SK, Goldstein JL, Anderson RGW, Brown MS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA. 1976:73:3178-3182.
12. Fraenkel-Conrat H. Methods for investigating the essential groups for enzyme activity. Methods Enzymol. 1957:4:247-269.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
14. Brown MS, Ho YK, Goldstein JL. The cholesteryl ester cycle in macrophage foam cells: continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J Biol Chem. 1980;255:9344-9352.
15. Hara A, Radin NS. Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem. 1978:90:420-426.